Mehmet Oz on GLP-1 medications for eligible seniors: recommends

Dr. Mehmet Oz recommends GLP-1 medications for eligible seniors, calling the drugs “life-changing and life-saving.” Oz says the Medicare GLP-1 Bridge program exists “to improve access, encourage better health outcomes and gather the data needed to inform future innovation.”

Oz’s stated reasoning is that the program helps beneficiaries get back to what he calls a “healthy fighting weight,” per the coverage of the program’s launch. He launched the Bridge on July 1, 2026, offering eligible Part D enrollees Wegovy, Zepbound, and Eli Lilly’s Foundayo obesity pill for a flat $50 per month through December 31, 2027, and pointed to early uptake — roughly 600,000 signups in the first two months, per Reuters’ reporting — as evidence of demand.

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.